These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27712796)

  • 1. Metastasis in Adult Brain Tumors.
    Barajas RF; Cha S
    Neuroimaging Clin N Am; 2016 Nov; 26(4):601-620. PubMed ID: 27712796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging diagnosis of brain metastasis.
    Barajas RF; Cha S
    Prog Neurol Surg; 2012; 25():55-73. PubMed ID: 22236668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphomas-Part 1.
    Brandão LA; Castillo M
    Neuroimaging Clin N Am; 2016 Nov; 26(4):511-536. PubMed ID: 27712792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced MR Imaging in Pediatric Brain Tumors, Clinical Applications.
    Lequin M; Hendrikse J
    Neuroimaging Clin N Am; 2017 Feb; 27(1):167-190. PubMed ID: 27889022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice.
    Boxerman JL; Shiroishi MS; Ellingson BM; Pope WB
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):649-670. PubMed ID: 27742108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain metastases--comparison of gadodiamide injection-enhanced MR imaging at standard and high dose, contrast-enhanced CT and non-contrast-enhanced MR imaging.
    Akeson P; Larsson EM; Kristoffersen DT; Jonsson E; Holtås S
    Acta Radiol; 1995 May; 36(3):300-6. PubMed ID: 7742127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Parotid Tumors With Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging.
    Abdel Razek AA; Samir S; Ashmalla GA
    J Comput Assist Tomogr; 2017 Jan; 41(1):131-136. PubMed ID: 27636248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast enhancement in primary tumors of the brain and spinal cord.
    Castillo M
    Neuroimaging Clin N Am; 1994 Feb; 4(1):63-80. PubMed ID: 8130953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced MR Imaging Techniques in Daily Practice.
    Mabray MC; Cha S
    Neuroimaging Clin N Am; 2016 Nov; 26(4):647-666. PubMed ID: 27712798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging of Brain Tumors Using Liposomal Contrast Agents and Nanoparticles.
    Mehta A; Ghaghada K; Mukundan S
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):751-763. PubMed ID: 27742115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of brain tumors.
    Chourmouzi D; Papadopoulou E; Marias K; Drevelegas A
    Surg Oncol Clin N Am; 2014 Oct; 23(4):629-84. PubMed ID: 25246045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perfusion measurement using the T2* contrast media dynamics in neuro-oncology. Physical basics and clinical applications].
    Weber MA; Risse F; Giesel FL; Schad LR; Kauczor HU; Essig M
    Radiologe; 2005 Jul; 45(7):618-32. PubMed ID: 15098092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Review of Computed Tomography and MR Perfusion Imaging in Neuro-Oncology.
    Trinh A; Wintermark M; Iv M
    Radiol Clin North Am; 2021 May; 59(3):323-334. PubMed ID: 33926680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
    Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
    Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Neoplasms of the Pediatric Brain.
    Jaimes C; Poussaint TY
    Radiol Clin North Am; 2019 Nov; 57(6):1163-1175. PubMed ID: 31582042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voxel-based correlation between coregistered single-photon emission computed tomography and dynamic susceptibility contrast magnetic resonance imaging in subjects with suspected Alzheimer disease.
    Cavallin L; Axelsson R; Wahlund LO; Oksengard AR; Svensson L; Juhlin P; Wiberg MK; Frank A
    Acta Radiol; 2008 Dec; 49(10):1154-61. PubMed ID: 18855165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brain metastases imaging].
    Delmaire C; Savatovsky J; Boulanger T; Dhermain F; Le Rhun E; Météllus P; Gerber S; Carsin-Nicole B; Petyt G
    Cancer Radiother; 2015 Feb; 19(1):16-9. PubMed ID: 25649387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.
    Jain R
    NMR Biomed; 2013 Aug; 26(8):1042-9. PubMed ID: 23832526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.